July 30 (Reuters) - U.S. drugmaker Pfizer ( PFE ) on
Tuesday raised its annual profit forecast after reporting
better-than-expected sales of its COVID vaccine and antiviral
treatment.
New Jersey-based Pfizer ( PFE ) now expects annual profit to be in
the range of $2.45 to $2.65 per share, compared with its prior
profit forecast of $2.15 to $2.35 per share.